146 related articles for article (PubMed ID: 6651138)
1. Transdermal scopolamine delivery system (TRANSDERM-V) and acute angle-closure glaucoma.
Hamill MB; Suelflow JA; Smith JA
Ann Ophthalmol; 1983 Nov; 15(11):1011-2. PubMed ID: 6651138
[TBL] [Abstract][Full Text] [Related]
2. Transdermal scopolamine in the prevention of motion sickness: evaluation of the time course of efficacy.
Homick JL; Kohl RL; Reschke MF; Degioanni J; Cintron-Trevino NM
Aviat Space Environ Med; 1983 Nov; 54(11):994-1000. PubMed ID: 6651736
[TBL] [Abstract][Full Text] [Related]
3. Transdermal scopolamine precipitating narrow-angle glaucoma.
Fraunfelder FT
N Engl J Med; 1982 Oct; 307(17):1079. PubMed ID: 7121520
[No Abstract] [Full Text] [Related]
4. Transdermal scopolamine in motion sickness.
Cronin CM; Sallan SE; Wolfe L
Pharmacotherapy; 1982; 2(1):29-31. PubMed ID: 6927209
[TBL] [Abstract][Full Text] [Related]
5. Transderm scopolamine efficacy related to time of application prior to the onset of motion.
Levy GD; Rapaport MH
Aviat Space Environ Med; 1985 Jun; 56(6):591-3. PubMed ID: 4015572
[TBL] [Abstract][Full Text] [Related]
6. Accidental mydriasis from scopolamine patches.
Rosen NB
J Am Optom Assoc; 1986 Jul; 57(7):541-2. PubMed ID: 3745760
[TBL] [Abstract][Full Text] [Related]
7. Transdermal scopolamine for motion sickness.
Med Lett Drugs Ther; 1981 Oct; 23(21):89-90. PubMed ID: 7027000
[No Abstract] [Full Text] [Related]
8. Transdermal scopolamine delivery system.
Hirsch D
Ann Ophthalmol; 1984 May; 16(5):406, 419. PubMed ID: 6742676
[No Abstract] [Full Text] [Related]
9. Transdermal scopolamine-induced psychosis.
Ziskind AA
Postgrad Med; 1988 Sep; 84(3):73-6. PubMed ID: 2901077
[TBL] [Abstract][Full Text] [Related]
10. Transdermal scopolamine: a review of its effects upon motion sickness, psychological performance, and physiological functioning.
Parrott AC
Aviat Space Environ Med; 1989 Jan; 60(1):1-9. PubMed ID: 2647072
[TBL] [Abstract][Full Text] [Related]
11. Scopoderm: transdermal hyoscine for motion sickness.
Drug Ther Bull; 1989 Nov; 27(23):91-2. PubMed ID: 2519317
[No Abstract] [Full Text] [Related]
12. Cycloplegia from transdermal scopolamine.
Chiaramonte JS
N Engl J Med; 1982 Jan; 306(3):174. PubMed ID: 7054664
[No Abstract] [Full Text] [Related]
13. Experimental motion sickness: efficacy of transdermal scopolamine plus ephedrine.
Graybiel A; Cramer DB; Wood CD
Aviat Space Environ Med; 1981 Jun; 52(6):337-9. PubMed ID: 7259691
[TBL] [Abstract][Full Text] [Related]
14. Transdermal scopolamine intoxication in a child.
Klein BL; Ashenburg CA; Reed MD
Pediatr Emerg Care; 1985 Dec; 1(4):208-9. PubMed ID: 3842169
[No Abstract] [Full Text] [Related]
15. Transderm Scop patches for prevention of motion sickness.
Johnson P; Hansen D; Matarazzo D; Petterson L; Swisher C; Trappolini A
N Engl J Med; 1984 Aug; 311(7):468-9. PubMed ID: 6749195
[No Abstract] [Full Text] [Related]
16. Effects of transdermal scopolamine upon psychological test performance at sea.
Parrott AC; Jones R
Eur J Clin Pharmacol; 1985; 28(4):419-23. PubMed ID: 4029247
[TBL] [Abstract][Full Text] [Related]
17. Influence of transdermal scopolamine on motion sickness during 7 days' exposure to heavy seas.
van Marion WF; Bongaerts MC; Christiaanse JC; Hofkamp HG; van Ouwerkerk W
Clin Pharmacol Ther; 1985 Sep; 38(3):301-5. PubMed ID: 4028625
[TBL] [Abstract][Full Text] [Related]
18. Transdermal scopolamine in the prevention of motion sickness at sea.
Price NM; Schmitt LG; McGuire J; Shaw JE; Trobough G
Clin Pharmacol Ther; 1981 Mar; 29(3):414-9. PubMed ID: 7009021
[TBL] [Abstract][Full Text] [Related]
19. More on Transderm Scop patches.
N Engl J Med; 1984 Nov; 311(21):1377-8. PubMed ID: 6493292
[No Abstract] [Full Text] [Related]
20. Transdermal scopolamine, oral meclizine, and placebo in motion sickness.
Dahl E; Offer-Ohlsen D; Lillevold PE; Sandvik L
Clin Pharmacol Ther; 1984 Jul; 36(1):116-20. PubMed ID: 6734040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
